Recent News

• 02.10.2026 - NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
• 12.16.2025 - NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
• 12.11.2025 - NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
• 11.11.2025 - NEXGEL Reports Third Quarter 2025 Financial Results
• 11.03.2025 - NEXGEL to Report Third Quarter 2025 Financial Results on November 11th
• 10.09.2025 - NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21

Recent Filings

• 02.10.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.30.2026 - 8-K Current report
• 01.07.2026 - 8-K Current report
• 12.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.22.2025 - 144 Report of proposed sale of securities
• 12.11.2025 - EX-99.1 EX-99.1
• 12.11.2025 - 8-K Current report
• 11.24.2025 - 8-K Current report
• 11.12.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]